Amneal Pharmaceuticals, Inc. initiated the U.S. commercialization of TEPADINA® (thiotepa) for Injection 200 mg in a patented multichambered bag. https://www.coherentmarketinsights.com/news/multichambered-bag-for-oncology-with-tepadinar-thiotepa-200-mg-launched-by-amneal-pharmaceuticals-1462